合成受容体によるインスリン分子認識
Jordan M Chinai1, Alexander B Taylor, Lisa M Ryno
1Department of Chemistry, Trinity University, One Trinity Place, San Antonio, Texas 78212, USA.
Journal of the American Chemical Society
|April 9, 2011
まとめ
合成受容体キュキュルビット[7]ウリル (Q7) は,ヒトインスリンをそのN端フェニララニン残基に選択的に結合させる. このタンパク質認識戦略は,分子結合アプリケーションのためのタンパク質端末のユニークな特性をターゲットにしています.
科学分野:
- 化学生物学 化学生物学とは
- 超分子化学とは
- プロテイン工学は,タンパク質の
背景:
- 選択的タンパク質結合のための分子の発見は,化学と生物学を前進させるために不可欠です.
- 合成受容体は,精密な分子認識の可能性を秘めています.
研究 の 目的:
- キュキュルビット[7]ウリル (Q7) とヒトインスリンとの結合相互作用を調査する.
- Q7インスリン結合のメカニズムと選択性を解明する.
主な方法:
- アイソテルミックタイトレーションカロリメトリ
- 光スペクトロスコピーは,光スペクトロスコピーを用います.
- X線結晶グラフィーです.
主要な成果:
- Q7は,1.5 × 10^6 M^-1.の結合定数を持つインスリンと結合する.
- Q7は,N端のアロマティック残留物とインスリン変種が欠けているより大きなタンパク質に対して,インスリンに対する高い選択性を示しています.
- 結晶構造は,N端のフェニララニン残基に結合し,末端が展開されていることを明らかにします.
結論:
- Q7によるタンパク質末端の認識は,末端残基の化学的性質と柔軟性によって引き起こされる.
- タンパク質末端をターゲットにすることは,選択的なタンパク質認識のための実行可能な戦略です.
- 発見はペプチド結合研究からの予測と一致し,アプローチを検証しています.
関連する概念動画
Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Internal Receptors
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...


